tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gregory Renza, 247 are a BUY (80.98%), 58 are a HOLD (19.02%).
Analyst Gregory Renza, currently employed at RBC, carries an average stock price target met ratio of 42.89% that have a potential upside of 36.31% achieved within 119 days.
Gregory Renza’s has documented 595 price targets and ratings displayed on 39 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CGON, CG Oncology, Common stock at 12-Jan-2026.
Analyst best performing recommendations are on SPRB (SPRUCE BIOSCIENCES ).
The best stock recommendation documented was for SPRB (SPRUCE BIOSCIENCES ) at 3/13/2024. The price target of $150 was fulfilled within 1 day with a profit of $239.25 (61.46%) receiving and performance score of 614.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Oct-2023
$40
$13.16 (49.03%)
$39
24 days ago
(06-Jan-2026)
2/6 (33.33%)
$13.85 (52.96%)
467
Hold Since 09-May-2024
$29
$2.16 (8.05%)
$24
1 months 28 days ago
(02-Dec-2025)
10/14 (71.43%)
$3.57 (14.04%)
157
Buy Since 10-Oct-2023
$31
$4.16 (15.50%)
$33
2 months 13 days ago
(17-Nov-2025)
8/14 (57.14%)
$6.98 (29.06%)
113
Buy Since 28-Feb-2024
$29
$2.16 (8.05%)
$28
2 months 24 days ago
(06-Nov-2025)
5/11 (45.45%)
$7.35 (33.95%)
312
Buy Since 23-Jun-2025
$32
$5.16 (19.23%)
$40
2 months 24 days ago
(06-Nov-2025)
0/3 (0%)
$10.35 (47.81%)
Which stock is Gregory Renza is most bullish on?
Which stock is Gregory Renza is most reserved on?
What Year was the first public recommendation made by Gregory Renza?
